Telegraph.co.uk

Nobel winner Yamanaka's priority goal: 'iPS Stock'
The Japan Times
In the iPS Stock project, Yamanaka plans to derive the cell lines from people with a special white blood cell type that is far less likely to lead to transplant rejection. Yamanaka said cells from a single donor would produce enough iPS cells for about ...
Nobel Prize for medicine awarded to Gurdon, Yamanaka for stem cell discoveriesWashington Post
2 win Nobel Prize in medicine for stem-cell discoveriesPittsburgh Post Gazette

all 2,685 news articles »